Workup for Erectile Dysfunction in Diabetics
All diabetic men with erectile dysfunction require a focused sexual and medical history, physical examination, morning serum total testosterone measurement, and cardiovascular risk assessment, as ED in diabetes is a sentinel marker for underlying cardiovascular disease and requires immediate attention to prevent mortality. 1
Essential Clinical Evaluation
History Components
- Onset and duration of symptoms (≥3 months defines persistent ED)
- Severity assessment using validated questionnaires (Sexual Health Inventory for Men or Erection Hardness Score)
- Presence of nocturnal/morning erections (suggests psychogenic component if present)
- Situational factors (partner-specific, context-dependent)
- Diabetes-specific factors: duration, glycemic control (HbA1c), presence of other diabetic complications (neuropathy, retinopathy, nephropathy, peripheral arterial disease)
Physical Examination
Focus on 3:
- Vital signs: blood pressure (hypertension increases ED risk 2.1-fold)
- Genital examination: structural abnormalities, Peyronie's disease
- Neurological assessment: peripheral neuropathy signs (autonomic neuropathy increases ED risk 5-fold in diabetics)
- Vascular assessment: peripheral pulses, signs of peripheral arterial disease (increases ED risk 2.8-fold)
Mandatory Laboratory Testing
Required Tests
- Morning serum total testosterone (mandatory in all diabetic men with ED)
- HbA1c (poor glycemic control increases ED risk 2.3-fold)
- Lipid profile (hyperlipidemia contributes to endothelial dysfunction)
- Thyroid function if clinically indicated
Critical caveat: Hypogonadism is significantly more prevalent in diabetic men with ED and requires identification before treatment initiation 4, 5.
Cardiovascular Risk Stratification
This is non-negotiable: ED in diabetics is an independent predictor of cardiovascular disease and mortality 3. The workup must include:
- Assessment for coronary artery disease symptoms
- Evaluation of traditional cardiovascular risk factors
- Recognition that new-onset or progressive ED signals threatening ischemic heart disease, even when asymptomatic
Specialized Testing Indications
Consider additional testing when 1, 2:
- Penile Doppler ultrasound: suspected vascular insufficiency or when surgical intervention considered
- Nocturnal penile tumescence testing: differentiating organic from psychogenic ED
- Neurophysiological testing: when severe neuropathy suspected and treatment planning requires confirmation
Psychosocial Assessment
Do not overlook: Even with documented neuropathic complications, psychiatric factors (anxiety, depression, sexual phobias) are important contributors 3. Screen for:
- Depression and anxiety disorders
- Relationship issues
- Performance anxiety
- Quality of life impact
Key Diabetic-Specific Risk Factors to Document
The following significantly increase ED risk in diabetics 3:
- Autonomic neuropathy (OR 5.0) - highest risk factor
- Diabetic foot (OR 4.0)
- Peripheral neuropathy (OR 3.3)
- Peripheral arterial disease (OR 2.8)
- Nephropathy (OR 2.3)
- Poor glycemic control (OR 2.3)
- Retinopathy (OR 2.2)
- Hypertension (OR 2.1)
- Diabetes duration (OR 2.0)
Common Pitfalls to Avoid
- Failing to measure testosterone: Hypogonadism is common in diabetics and must be identified before PDE5 inhibitor therapy 6, 5
- Ignoring cardiovascular assessment: ED may be the first manifestation of cardiovascular disease in diabetics 3
- Overlooking medication review: Antihypertensives, antidepressants, and other drugs commonly used in diabetics cause ED 2
- Assuming purely organic etiology: Psychogenic components coexist even with documented neuropathy 3
When to Refer for Specialized Evaluation
Referral to sexual medicine specialist or urologist indicated when 1:
- Complex cases requiring specialized testing
- Non-response to first-line therapy
- Consideration of surgical interventions
- Significant anatomical abnormalities
- Need for mental health professional integration to reduce performance anxiety and improve treatment adherence
The workup must be comprehensive yet focused, recognizing that diabetic ED is multifactorial with neuropathy, vasculopathy, hormonal abnormalities, and psychogenic factors all contributing 3, 4, 7. This approach prioritizes identifying modifiable risk factors and life-threatening cardiovascular disease while establishing baseline severity for treatment monitoring.